These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9049585)

  • 1. Lack of interaction between meloxicam and warfarin in healthy volunteers.
    Türck D; Su CA; Heinzel G; Busch U; Bluhmki E; Hoffmann J
    Eur J Clin Pharmacol; 1997; 51(5):421-5. PubMed ID: 9049585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady-state pharmacokinetics of lithium in healthy volunteers receiving concomitant meloxicam.
    Türck D; Heinzel G; Luik G
    Br J Clin Pharmacol; 2000 Sep; 50(3):197-204. PubMed ID: 10971303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of meloxicam on furosemide pharmacokinetics and pharmacodynamics in healthy volunteers.
    Müller FO; Schall R; de Vaal AC; Groenewoud G; Hundt HK; Middle MV
    Eur J Clin Pharmacol; 1995; 48(3-4):247-51. PubMed ID: 7589049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of linagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
    Graefe-Mody EU; Brand T; Ring A; Withopf B; Stangier J; Iovino M; Woerle HJ
    Int J Clin Pharmacol Ther; 2011 May; 49(5):300-10. PubMed ID: 21543033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of fimasartan, an angiotensin receptor type 1 blocker, on the pharmacokinetics and pharmacodynamics of warfarin in healthy Korean male volunteers: a one-sequence, two-period crossover clinical trial.
    Gu N; Kim BH; Lim KS; Kim SE; Nam WS; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2012 Jul; 34(7):1592-600. PubMed ID: 22727611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of meloxicam on the pharmacokinetics of beta-acetyl-digoxin.
    Degner FL; Heinzel G; Narjes H; Türck D
    Br J Clin Pharmacol; 1995 Nov; 40(5):486-8. PubMed ID: 8703654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism between dexketoprofen and meloxicam in an orofacial formalin test was not modified by opioid antagonists.
    Gonzalez C; Zegpi C; Noriega V; Prieto JC; Miranda HF
    Pharmacol Rep; 2011; 63(2):433-40. PubMed ID: 21602598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
    Br J Clin Pharmacol; 2005 Apr; 59(4):425-32. PubMed ID: 15801937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fesoterodine on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
    Malhotra B; Alvey C; Gong J; Li X; Duczynski G; Gandelman K
    Br J Clin Pharmacol; 2011 Aug; 72(2):257-62. PubMed ID: 21496065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of a meaningful effect of anacetrapib on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Krishna R; Stypinski D; Ali M; Garg A; Cote J; Maes A; Degroot B; Liu Y; Li S; Connolly SM; Wagner JA; Stoch SA
    Br J Clin Pharmacol; 2012 Jul; 74(1):116-24. PubMed ID: 22243494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium.
    Modi NB; Kell S; Simon M; Vargas R
    J Clin Pharmacol; 2005 Aug; 45(8):919-26. PubMed ID: 16027402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of drug interaction between warfarin and nonsteroidal anti-inflammatory drugs in practical setting.
    Choi KH; Kim AJ; Son IJ; Kim KH; Kim KB; Ahn H; Lee EB
    J Korean Med Sci; 2010 Mar; 25(3):337-41. PubMed ID: 20191029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of repeated administration of levetiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin.
    Ragueneau-Majlessi I; Levy RH; Meyerhoff C
    Epilepsy Res; 2001 Nov; 47(1-2):55-63. PubMed ID: 11673021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects.
    Moore KT; Byra W; Vaidyanathan S; Natarajan J; Ariyawansa J; Salih H; Turner KC
    Br J Clin Pharmacol; 2015 Jun; 79(6):907-17. PubMed ID: 25475601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nilotinib on single-dose warfarin pharmacokinetics and pharmacodynamics: a randomized, single-blind, two-period crossover study in healthy subjects.
    Yin OQ; Gallagher N; Fischer D; Zhao L; Zhou W; Leroy E; Golor G; Schran H
    Clin Drug Investig; 2011; 31(3):169-79. PubMed ID: 21184622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple doses of sitagliptin, a selective DPP-4 inhibitor, do not meaningfully alter pharmacokinetics and pharmacodynamics of warfarin.
    Wright DH; Herman GA; Maes A; Liu Q; Johnson-Levonas AO; Wagner JA
    J Clin Pharmacol; 2009 Oct; 49(10):1157-67. PubMed ID: 19783710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of meloxicam with cimetidine, Maalox, or aspirin.
    Busch U; Heinzel G; Narjes H; Nehmiz G
    J Clin Pharmacol; 1996 Jan; 36(1):79-84. PubMed ID: 8932547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cholestyramine on the pharmacokinetics of meloxicam, a new non-steroidal anti-inflammatory drug (NSAID), in man.
    Busch U; Heinzel G; Narjes H
    Eur J Clin Pharmacol; 1995; 48(3-4):269-72. PubMed ID: 7589053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of tecarfarin, a novel vitamin K antagonist oral anticoagulant.
    Albrecht D; Ellis D; Canafax DM; Combs D; Druzgala P; Milner PG; Midei MG
    Thromb Haemost; 2017 Apr; 117(4):706-717. PubMed ID: 28180234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.